Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1574.6000 13.80 (0.88%)
NSE Sep 12, 2025 15:31 PM
Volume: 785.5K
 

logo
Cipla Ltd.
23 May 2019
1574.60
0.88%
ICICI Securities Limited
Q4FY19 revenues grew 19.1% YoY to | 4404 crore (I-direct estimate: | 3783 crore) mainly due to 69% YoY growth in the US to | 1143 crore (I-direct estimate: | 814.3 crore) led by launched of gSensipar at risk. Domestic revenues grew 10.9% YoY to | 1500 crore (I-direct estimate: | 1420.7 crore). EBITDA margins improved 676 bps YoY to 21.8% (I-direct estimate: 16.1%) due to mainly due to gSensipar launch. EBITDA grew 72.6% YoY to | 961 crore (I-direct estimate: | 607.9 crore). Net profit grew 60.9% YoY to | 383...
Cipla Ltd. is trading above all available SMAs
More from Cipla Ltd.
Recommended